BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Busek P, Duke-cohan JS, Sedo A. Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease? Cancers 2022;14:2072. [DOI: 10.3390/cancers14092072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Eitah HE, Attia HN, Soliman AAF, Gamal El Din AA, Mahmoud K, Sayed RH, Maklad YA, El-Sahar AE. Vitamin D ameliorates diethylnitrosamine-induced liver preneoplasia: A pivotal role of CYP3A4/CYP2E1 via DPP-4 enzyme inhibition. Toxicol Appl Pharmacol 2023;458:116324. [PMID: 36442531 DOI: 10.1016/j.taap.2022.116324] [Reference Citation Analysis]
2 Cordero OJ. CD26 and Cancer. Cancers 2022;14:5194. [DOI: 10.3390/cancers14215194] [Reference Citation Analysis]
3 Chiara LD, Barcia-castro L, Gallardo-gómez M, Cadena MPDL, Martínez-zorzano VS, Rodríguez-berrocal FJ, Bujanda L, Etxart A, Castells A, Balaguer F, Jover R, Cubiella J, Cordero OJ. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers 2022;14:4563. [DOI: 10.3390/cancers14194563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee JY, Park M. The Role of Serum CD26 in the Diagnosis of Gastric Cancer. IJGM 2022;Volume 15:7179-7187. [DOI: 10.2147/ijgm.s378620] [Reference Citation Analysis]
5 Hu X, Wang X, Xue X. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. Molecules 2022;27:4498. [DOI: 10.3390/molecules27144498] [Reference Citation Analysis]